Evidence map›Paper›PMID 33856804›Full record

ArticleJournal of the American Chemical Society2021

Enantioselective Hydrothiolation: Diverging Cyclopropenes through Ligand Control.

Shaozhen Nie, Alexander Lu, Erin L Kuker, Vy M Dong

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Total Synthesis and Stereochemical Assignment of Enteropeptin A.Journal of the American Chemical Society · 2024
    Article
  6. Article
  7. Article
  8. Enantioselective Hydroalkoxylation of 1,3-Dienes via Ni-Catalysis.Journal of the American Chemical Society · 2023
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shaozhen NieDepartment of Chemistry, University of California, Irvine, Irvine, California 92697, United States.
Alexander LuDepartment of Chemistry, University of California, Irvine, Irvine, California 92697, United States.
Erin L KukerDepartment of Chemistry, University of California, Irvine, Irvine, California 92697, United States.
Vy M DongDepartment of Chemistry, University of California, Irvine, Irvine, California 92697, United States.ORCID 0000-0002-8099-1048

Funding

Innovative Tools for Chemical Synthesis: Metal-Hydride Catalysis, Medicinal Motifs, and Molecular ProbesR35GM127071 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI Vy M Dong · 2018 to 2026
$4.9M
NIGMS NIH HHS R35 GM127071
6 · The paper itself

Abstract

In this article, we advance Rh-catalyzed hydrothiolation through the divergent reactivity of cyclopropenes. Cyclopropenes undergo hydrothiolation to provide cyclopropyl sulfides or allylic sulfides. The choice of bisphosphine ligand dictates whether the pathway involves ring-retention or ring-opening. Mechanistic studies reveal the origin for this switchable selectivity. Our results suggest the two pathways share a common cyclopropyl-Rh(III) intermediate. Electron-rich Josiphos ligands promote direct reductive elimination from this intermediate to afford cyclopropyl sulfides in high enantio- and diastereoselectivities. Alternatively, atropisomeric ligands (such as DTBM-BINAP) enable ring-opening from the cyclopropyl-Rh(III) intermediate to generate allylic sulfides with high enantio- and regiocontrol.

Indexed as

LigandsAllyl CompoundsCatalysisCoordination ComplexesCyclopropanesRhodiumStereoisomerismSulfhydryl CompoundsSulfidesAllyl Compoundsallyl sulfideCoordination ComplexesCyclopropanescyclopropeneLigandsRhodiumSulfhydryl CompoundsSulfides

Identifiers

PMID33856804
PMCPMC8842840

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.